| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.837 | 0.001 | 0.837 | Benzodiazepine agonist | 0.817 0.001 CID_119094 | ||
| 0.813 | 0.004 | 0.813 | Platelet aggregation inhibitor | 0.739 0.004 CID_119094 | ||
| 0.794 | 0.002 | 0.794 | GABA receptor agonist | 0.743 0.003 CID_119094 | ||
| 0.776 | 0.004 | 0.776 | Platelet activating factor antagonist | 0.694 0.004 CID_119094 | ||
| 0.753 | 0.005 | 0.779 | Anticonvulsant | 0.779 0.004 CID_119094 | CID_119094 | |
| 0.617 | 0.006 | 0.624 | GABA C receptor rho-3 antagonist | 0.624 0.005 CID_119094 | CID_119094 | |
| 0.615 | 0.005 | 0.615 | Psychostimulant | 0.499 0.011 CID_119094 | ||
| 0.466 | 0.003 | 0.466 | GABA A receptor antagonist | 0.299 0.004 CID_119094 | ||
| 0.445 | 0.004 | 0.445 | GABA receptor antagonist | 0.292 0.004 CID_119094 | ||
| 0.269 | 0.005 | 0.269 | GABA A receptor agonist | 0.211 0.009 CID_119094 | ||
| 0.282 | 0.042 | 0.282 | Sigma receptor agonist | |||
| 0.331 | 0.108 | 0.331 | MAP kinase kinase 6 inhibitor | |||
| 0.234 | 0.015 | 0.289 | GABA C receptor rho-2 antagonist | 0.289 0.006 CID_119094 | CID_119094 | |
| 0.21 | 0.005 | 0.21 | Vasopressin 1 antagonist | 0.162 0.005 CID_119094 | ||
| 0.322 | 0.125 | 0.322 | Analgesic | 0.261 0.173 CID_119094 | ||
| 0.199 | 0.005 | 0.199 | Antidiuretic hormone antagonist | 0.151 0.007 CID_119094 | ||
| 0.252 | 0.062 | 0.252 | Cyclic AMP phosphodiesterase inhibitor | |||
| 0.243 | 0.074 | 0.276 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.276 0.039 CID_119094 | CID_119094 | |
| 0.17 | 0.005 | 0.17 | Bromodomain-containing protein 2 inhibitor | 0.154 0.008 CID_119094 | ||
| 0.157 | 0.003 | 0.157 | Benzodiazepine antagonist | 0.088 0.004 CID_119094 | ||
| 0.14 | 0.007 | 0.14 | Bromodomain-containing protein 4 inhibitor | 0.138 0.008 CID_119094 | ||
| 0.233 | 0.101 | 0.293 | Gastrin inhibitor | 0.293 0.038 CID_119094 | CID_119094 | |
| 0.13 | 0.004 | 0.13 | Bromodomain-containing protein 3 inhibitor | 0.119 0.004 CID_119094 | ||
| 0.123 | 0.005 | 0.123 | Vasopressin 1A antagonist | 0.096 0.005 CID_119094 | ||
| 0.11 | 0.007 | 0.132 | Cholecystokinin A antagonist | 0.132 0.005 CID_119094 | CID_119094 | |
| 0.109 | 0.008 | 0.109 | Phosphodiesterase 1A inhibitor | 0.061 0.039 CID_119094 | ||
| 0.172 | 0.081 | 0.172 | MAP kinase kinase 5 inhibitor | |||
| 0.095 | 0.01 | 0.095 | Oxytocin antagonist | 0.067 0.014 CID_119094 | ||
| 0.092 | 0.009 | 0.106 | Cholecystokinin antagonist | 0.106 0.008 CID_119094 | CID_119094 | |
| 0.108 | 0.037 | 0.108 | Histamine H1 receptor antagonist | |||
| 0.097 | 0.027 | 0.116 | Protein kinase B beta inhibitor | 0.116 0.017 CID_119094 | CID_119094 | |
| 0.112 | 0.044 | 0.112 | Phosphodiesterase 7B inhibitor | 0.094 0.065 CID_119094 | ||
| 0.118 | 0.054 | 0.128 | GABA C receptor antagonist | 0.128 0.045 CID_119094 | CID_119094 | |
| 0.111 | 0.049 | 0.142 | GABA C receptor rho-1 antagonist | 0.142 0.025 CID_119094 | CID_119094 | |
| 0.109 | 0.049 | 0.109 | Pim-1 kinase inhibitor | |||
| 0.114 | 0.056 | 0.114 | Interleukin 2 antagonist | 0.109 0.066 CID_119094 | ||
| 0.203 | 0.154 | 0.203 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.199 0.158 CID_119094 | ||
| 0.07 | 0.023 | 0.07 | Phosphodiesterase II inhibitor | 0.061 0.031 CID_119094 | ||
| 0.051 | 0.006 | 0.051 | Benzodiazepine receptor peripheral-type antagonist | 0.038 0.016 CID_119094 | ||
| 0.114 | 0.071 | 0.114 | Cholesterol synthesis inhibitor | |||
| 0.062 | 0.022 | 0.069 | Purinergic P2X antagonist | 0.069 0.018 CID_119094 | CID_119094 | |
| 0.062 | 0.023 | 0.062 | Phosphodiesterase 2A inhibitor | 0.053 0.03 CID_119094 | ||
| 0.067 | 0.034 | 0.067 | Phosphodiesterase 1C inhibitor | |||
| 0.091 | 0.058 | 0.091 | Phosphodiesterase I inhibitor | |||
| 0.045 | 0.018 | 0.045 | Purinergic P2X7 antagonist | 0.041 0.02 CID_119094 | ||
| 0.044 | 0.017 | 0.044 | CF transmembrane conductance regulator antagonist | 0.038 0.032 CID_119094 | ||
| 0.066 | 0.042 | 0.08 | Purinergic P2 antagonist | 0.08 0.033 CID_119094 | CID_119094 | |
| 0.05 | 0.026 | 0.051 | Benzodiazepine inverse agonist | 0.051 0.024 CID_119094 | CID_119094 | |
| 0.128 | 0.106 | 0.128 | Pregnane X receptor agonist | |||
| 0.056 | 0.038 | 0.056 | MAP kinase kinase 9 inhibitor | |||
| 0.118 | 0.1 | 0.128 | Nav1.6 sodium channel blocker | 0.128 0.084 CID_119094 | CID_119094 | |
| 0.073 | 0.059 | 0.076 | GABA B receptor agonist | 0.076 0.052 CID_119094 | CID_119094 | |
| 0.043 | 0.029 | 0.044 | Alpha 1L adrenoreceptor agonist | 0.044 0.028 CID_119094 | CID_119094 | |
| 0.057 | 0.048 | 0.095 | Adrenaline uptake inhibitor | 0.095 0.02 CID_119094 | CID_119094 | |
| 0.161 | 0.153 | 0.161 | Spasmolytic | |||
| 0.04 | 0.034 | 0.04 | Nerve growth factor antagonist | |||
| 0.163 | 0.163 | 0.165 | 5 Hydroxytryptamine 3E antagonist | 0.165 0.155 CID_119094 | CID_119094 | |
| 0.041 | 0.045 | 0.043 | Parathyroid hormone antagonist | 0.043 0.039 CID_119094 | CID_119094 | |
| 0.039 | 0.046 | 0.046 | AMPA receptor antagonist | 0.046 0.035 CID_119094 | CID_119094 | |
| 0.099 | 0.113 | 0.132 | Sodium channel (voltage-gated) blocker | 0.132 0.071 CID_119094 | CID_119094 | |
| 0.017 | 0.038 | 0.04 | Poly(ADP-ribose) polymerase 2 inhibitor | 0.04 0.012 CID_119094 | CID_119094 | |
| 0.044 | 0.076 | 0.056 | 5 Hydroxytryptamine 7 agonist | 0.056 0.038 CID_119094 | CID_119094 | |
| 0.035 | 0.077 | 0.086 | 5 Hydroxytryptamine uptake inhibitor | 0.086 0.032 CID_119094 | CID_119094 | |
| 0.028 | 0.071 | 0.036 | 5 Hydroxytryptamine 2B agonist | 0.036 0.034 CID_119094 | CID_119094 | |
| 0.227 | 0.329 | 0.283 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.283 0.236 CID_119094 | CID_119094 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |